Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives

Figure 1 The risk factors and biological mechanisms of metabolic dysfunction-associated steatotic liver disease. AMPK: AMP-activated protein kinase; CPT1: Carnitine palmitoyltransferase I; ER: Endoplasmic reticulum; HCC: Hepatocellular carcinoma; IL: Interleukin; JNK: C-Jun N-terminal kinase; MASLD: Metabolic dysfunction-associated steatotic liver disease; PPR-α: Peroxisome proliferator-activated receptor-alpha; ROS: Reactive oxygen species; Sirt: Sirtuin; Stat3: Signal transducer and activator of transcription 3; TNF-α: Tumor necrosis factor-alpha.

Figure 2 Factors that define transient elastography diagnostic accuracy. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; HCC: Hepatocellular carcinoma; TE: Transient elastography.